Active Biotech AB - Company Profile
Powered by 
All the sales intelligence you need on Active Biotech AB in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Active Biotech AB fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Active Biotech AB.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Active Biotech AB (Active Biotech) focuses on the development of drugs for cancer and modulate the body's own immune system. Emphasis on R&D activities, strategic alliances and collaborations, and product candidate, naptumomab, are its strengths, whereas dependence on external financing is a matter of concern to the company. Pipeline portfolio, regulatory approval, and market potential of multiple sclerosis (MS) can provide new growth avenues to the company. However, stringent regulations, dependence on subcontractors, and increasing competitive pressures could adversely affect its future operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer